yep CSL112 will be massive. and IMO after the aegisII trial, I reckon there will be trials of whether it will be able to be used as a prophylactic agent to reduce LDL instead of just for preventing a reccurent MI - and that could be absolutely massive as it would have the same market as statins.
short csl, page-31
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$297.50 |
Change
2.600(0.88%) |
Mkt cap ! $143.7B | |||
| Open | High | Low | Value | Volume |
| $297.44 | $299.00 | $297.16 | $161.2M | 541.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 944 | $297.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $297.50 | 1699 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |